Literature DB >> 25381183

Alleviating waiting impulsivity and perseverative responding by μ-opioid receptor antagonism in two inbred mouse strains.

Sandra Sanchez-Roige1, Tamzin L Ripley, David N Stephens.   

Abstract

RATIONALE: Recent evidence has implicated the opioid system in exaggerated ethanol consumption and impulsivity deficits. The opioid receptor antagonist naltrexone (NTX) has proven efficient in reducing alcohol consumption; however, its role on impulsive behaviour is not fully characterised.
OBJECTIVE: The aim of this study was to investigate the effects of NTX on two measures of impulsive behaviour in two inbred mouse strains that differ in ethanol preference and impulsive phenotype.
METHODS: Two separate groups of C57BL/6J (B6, n = 24) and DBA2/J (D2, n = 24) male mice were exposed to intermittent ethanol (IEE; 2 g/kg) during early (PND 30-45, IEE_Early) or late (PND 45-60, IEE_Late) adolescence or the respective saline control. The ability of NTX (10 mg/kg) alone, or co-administered with ethanol (0.5 g/kg), to diminish waiting impulsivity in the five-choice serial reaction time task (5-CSRTT), or improve decision-making in a mouse version of the Iowa Gambling Task (mIGT), was examined in adulthood.
RESULTS: In the 5-CSRTT, NTX diminished impulsivity in both strains of mice, irrespective of previous ethanol experience. In the mIGT, NTX failed to alter risky decision-making but decreased perseverative responding.
CONCLUSIONS: Blocking the actions of endogenous opioids may attenuate waiting impulsivity, in addition to alleviating perseverative responding. In a broader context, μ-opiate antagonism may be of potential interest for impulse-control disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25381183     DOI: 10.1007/s00213-014-3786-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  65 in total

1.  Differences in the peripheral levels of beta-endorphin in response to alcohol and stress as a function of alcohol dependence and family history of alcoholism.

Authors:  Xing Dai; Joseph Thavundayil; Christina Gianoulakis
Journal:  Alcohol Clin Exp Res       Date:  2005-11       Impact factor: 3.455

2.  Impact of strain and D-amphetamine on impulsivity (delay discounting) in inbred mice.

Authors:  Christa M Helms; Jamie M Reeves; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

3.  Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls.

Authors:  Jennifer M Mitchell; Venessa C Tavares; Howard L Fields; Mark D'Esposito; Charlotte A Boettiger
Journal:  Neuropsychopharmacology       Date:  2006-10-18       Impact factor: 7.853

4.  Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.

Authors:  Jared W Young; Jordy van Enkhuizen; Catharine A Winstanley; Mark A Geyer
Journal:  J Psychopharmacol       Date:  2011-03-18       Impact factor: 4.153

Review 5.  The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry.

Authors:  T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2002-08-09       Impact factor: 4.530

6.  Content of dynorphins and kappa-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice.

Authors:  N T Jamensky; C Gianoulakis
Journal:  Alcohol Clin Exp Res       Date:  1997-11       Impact factor: 3.455

7.  A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.

Authors:  Jon E Grant; Suck Won Kim; Brian L Odlaug
Journal:  Biol Psychiatry       Date:  2009-02-12       Impact factor: 13.382

8.  Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies.

Authors:  N C Raymond; J E Grant; S W Kim; E Coleman
Journal:  Int Clin Psychopharmacol       Date:  2002-07       Impact factor: 1.659

9.  Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task.

Authors:  Fiona D Zeeb; Trevor W Robbins; Catharine A Winstanley
Journal:  Neuropsychopharmacology       Date:  2009-06-17       Impact factor: 7.853

10.  Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people.

Authors:  Hugh Myrick; Raymond F Anton; Xingbao Li; Scott Henderson; Patrick K Randall; Konstantin Voronin
Journal:  Arch Gen Psychiatry       Date:  2008-04
View more
  4 in total

1.  The Mouse Gambling Task: Assessing Individual Decision-making Strategies in Mice.

Authors:  Elsa Pittaras; Arnaud Rabat; Sylvie Granon
Journal:  Bio Protoc       Date:  2020-01-05

2.  Naltrexone differentially modulates the neural correlates of motor impulse control in abstinent alcohol-dependent and polysubstance-dependent individuals.

Authors:  Liam J Nestor; Louise M Paterson; Anna Murphy; John McGonigle; Csaba Orban; Laurence Reed; Eleanor Taylor; Remy Flechais; Dana Smith; Edward T Bullmore; Karen D Ersche; John Suckling; Rebecca Elliott; Bill Deakin; Ilan Rabiner; Anne Lingford Hughes; Barbara J Sahakian; Trevor W Robbins; David J Nutt
Journal:  Eur J Neurosci       Date:  2018-11-26       Impact factor: 3.386

3.  Mouse and Human Genetic Analyses Associate Kalirin with Ventral Striatal Activation during Impulsivity and with Alcohol Misuse.

Authors:  Yolanda Peña-Oliver; Fabiana M Carvalho; Sandra Sanchez-Roige; Erin B Quinlan; Tianye Jia; Tom Walker-Tilley; Stuart L Rulten; Frances M G Pearl; Tobias Banaschewski; Gareth J Barker; Arun L W Bokde; Christian Büchel; Patricia J Conrod; Herta Flor; Jürgen Gallinat; Hugh Garavan; Andreas Heinz; Penny Gowland; Marie-Laure Paillere Martinot; Tomáš Paus; Marcella Rietschel; Trevor W Robbins; Michael N Smolka; Gunter Schumann; David N Stephens
Journal:  Front Genet       Date:  2016-04-07       Impact factor: 4.599

4.  Incidental rewarding cues influence economic decisions in people with obesity.

Authors:  Jakob Simmank; Carsten Murawski; Stefan Bode; Annette Horstmann
Journal:  Front Behav Neurosci       Date:  2015-10-15       Impact factor: 3.558

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.